Dynamic Chart

Last Transcript: Taro Pharmaceutical Industries Ltd.

Insider TitleAgeSince
Director of Finance/CFO 69 07-12-31
Chief Operating Officer - 01-12-31
Chief Tech/Sci/R&D Officer 59 11-09-30
Insider TitleAgeSince
Director/Board Member 73 20-01-31
Chairman 68 10-09-21
Director/Board Member 67 10-08-31
More insiders
Logo Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
Employees
1,554
More about the company